Alan Quasha Business World

No one more than Alan Quasha, chairman of the American Brain Trauma Foundation, wants to help victims of traumatic brain injury (TBI).  The work and research undertaken at the BTF makes advances in this area all the time, but still there is much that needs to be understood about this very complex injury.  That is why research that has been going on at Emory University’s School of Medicine in this area is of significant interest to all interested parties.

Emory Researchers and Alan Quasha

The recent study undertaken by the researchers from Emory University already found, some years back that when TBI victims were given progesterone shortly after their injury, there was a chance the risk of long-term disability and death would be reduced.  Indeed, using progesterone indicated a 50 percent mortality reduction compared to those patients who did not take the drug.  As well, those suffering from moderate brain injuries who took progesterone showed improved levels of functionality and lower disability statistics.  This news is definitely positive for Alan Quasha and his team at the BTF.

The Brain Trauma Foundation works tirelessly to help to decrease the rate of brain trauma injuries and to educate medical personnel about how to work with brain trauma victims.  Many people don’t realize that the permanent damage associated with brain trauma doesn’t happen instantaneously.  The ensuing hours and days after a brain injury greatly influence the outcome.

The Centers for Disease Control and Prevention has found that if the BTF Guidelines were used more routinely, there would actually be a 50% decrease in deaths, improved quality of life and cost savings of around $3.8 billion a year!